What’s New from the 2016 ESMO Clinical Guidelines

Update to the “Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors”

National Comprehensive Cancer Network NSCLC Guideline Updates for 2016: Non-Small Cell Lung Cancer

Multifaceted Initiative Launches Aimed at Reducing Lung Cancer Deaths 25% by 2030

COVID-19 and Lung Cancer

The Art and Science of Patient–Doctor Communication

In Brief for February 9, 2022

Multidisciplinary Tumor Boards: Six Eyes See More than Two

Unplanned Hospital Care in Patients With NSCLC

Predicting Early Weight Loss in Radiotherapy

Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study

Novel Targets and Therapies: KEAP1- and NFE2L2-Mutant Squamous Cell Lung Cancer